Extended prophylaxis treatment with fondaparinux is cost effective compared with enoxaparin after hip fracture surgery.

被引：0

作者：

Sullivan, SD

Kwong, L

机构：

[1] Univ Washington, Dept Pharm & Hlth Serv, Seattle, WA 98195 USA

[2] Univ Calif Los Angeles, Harbor Med Ctr, Dept Orthopaed, Los Angeles, CA 90024 USA

来源：

BLOOD | 2003年 / 102卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5771

引用

页码：510B / 510B

页数：1

共 50 条

[1] The incremental cost per life year saved of extended prophylaxis with fondaparinux versus enoxaparin after hip fracture surgery.
Sullivan, SD
Kwong, L
[J]. BLOOD, 2003, 102 (11) : 502A - 502A
[2] Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery.
Eriksson, BI
Bauer, KA
Lassen, MR
Turpie, AGG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18): : 1298 - 1304
[3] Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery
Sullivan, SD
Kwong, L
Nutescu, E
[J]. VALUE IN HEALTH, 2006, 9 (02) : 68 - 76
[4] Cost effectiveness of fondaparinux compared with enoxaparin for extended prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery using Dutch estimates of costs
Van Hout, B
[J]. VALUE IN HEALTH, 2005, 8 (06) : A116 - A116
[5] Fondaparinux is cost-effective compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing surgery for hip replacement.
Sullivan, SD
Kahn, SR
Muntz, JE
[J]. PHARMACOTHERAPY, 2003, 23 (10): : 1355 - 1355
[6] A cost effectiveness analysis of extending prophylaxis from one week to four weeks with fondaparinux after hip fracture surgery.
Sullivan, SD
Kwong, L
[J]. BLOOD, 2003, 102 (11) : 502A - 502A
[7] Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing major orthopedic surgery.
Sullivan, SD
Davidson, BL
Kahn, SR
Muntz, JE
Oster, G
Raskob, GE
[J]. BLOOD, 2002, 100 (11) : 871A - 871A
[8] Cost analyses of extended prophylaxis with enoxaparin after hip arthroplasty
Friedman, RJ
Dunsworth, GA
[J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2000, (370) : 171 - 182
[9] COST-EFFECTIVENESS ANALYSIS OF EXTENDED THROMBOPROPHYLAXIS IN HIP FRACTURE: FONDAPARINUX VERSUS ENOXAPARIN
Francisco Javier, Carrera Hueso
Auxiliadora, Ramon Barrios
Jose Adolfo, Carrera Hueso
Jaime Eduardo, Poquet Jornet
[J]. ATENCION FARMACEUTICA, 2010, 12 (03): : 144 - 155
[10] Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
Bauer, KA
Eriksson, BI
Lassen, MR
Turpie, AGG
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (18): : 1305 - 1310

← 1 2 3 4 5 →